These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 25496902)

  • 1. Tau imaging: early progress and future directions.
    Villemagne VL; Fodero-Tavoletti MT; Masters CL; Rowe CC
    Lancet Neurol; 2015 Jan; 14(1):114-24. PubMed ID: 25496902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau imaging in the study of ageing, Alzheimer's disease, and other neurodegenerative conditions.
    Villemagne VL; Okamura N
    Curr Opin Neurobiol; 2016 Feb; 36():43-51. PubMed ID: 26397020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untangling tau imaging.
    Villemagne VL; Okamura N; Rowe CC
    Alzheimers Dement (Amst); 2016; 4():39-42. PubMed ID: 27489878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo tau imaging: obstacles and progress.
    Villemagne VL; Okamura N
    Alzheimers Dement; 2014 Jun; 10(3 Suppl):S254-64. PubMed ID: 24924676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voyage au bout de la nuit: Aβ and tau imaging in dementias.
    Zwan MD; Okamura N; Fodero-Tavoletti MT; Furumoto S; Masters CL; Rowe CC; Villemagne VL
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):398-412. PubMed ID: 25358680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau imaging in neurodegenerative diseases.
    Dani M; Brooks DJ; Edison P
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1139-50. PubMed ID: 26572762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging biomarkers in tauopathies.
    Dani M; Edison P; Brooks DJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S26-8. PubMed ID: 26299160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developments in Tau PET Imaging.
    Zimmer ER; Leuzy A; Gauthier S; Rosa-Neto P
    Can J Neurol Sci; 2014 Sep; 41(5):547-53. PubMed ID: 25424608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
    Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
    Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Tau and Its Ligands in PET Imaging.
    Harada R; Okamura N; Furumoto S; Tago T; Yanai K; Arai H; Kudo Y
    Biomolecules; 2016 Jan; 6(1):7. PubMed ID: 26751494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau imaging with PET: an overview of challenges, current progress, and future applications.
    Robertson JS; Rowe CC; Villemagne VL
    Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):405-413. PubMed ID: 28750496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New advances in tau imaging in parkinsonism.
    Valli M; Strafella AP
    Int Rev Psychiatry; 2017 Dec; 29(6):628-635. PubMed ID: 29206491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
    Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for tau pathology.
    Schöll M; Maass A; Mattsson N; Ashton NJ; Blennow K; Zetterberg H; Jagust W
    Mol Cell Neurosci; 2019 Jun; 97():18-33. PubMed ID: 30529601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau PET imaging: present and future directions.
    Saint-Aubert L; Lemoine L; Chiotis K; Leuzy A; Rodriguez-Vieitez E; Nordberg A
    Mol Neurodegener; 2017 Feb; 12(1):19. PubMed ID: 28219440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Imaging of Extrapyramidal Movement Disorders With Dementia: The 4R Tauopathies.
    Frey KA
    Semin Nucl Med; 2021 May; 51(3):275-285. PubMed ID: 33431202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive imaging of tau-targeted probe uptake by whole brain multi-spectral optoacoustic tomography.
    Vagenknecht P; Luzgin A; Ono M; Ji B; Higuchi M; Noain D; Maschio CA; Sobek J; Chen Z; Konietzko U; Gerez JA; Riek R; Razansky D; Klohs J; Nitsch RM; Dean-Ben XL; Ni R
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2137-2152. PubMed ID: 35128565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease.
    Scheltens P; Blennow K; Breteler MM; de Strooper B; Frisoni GB; Salloway S; Van der Flier WM
    Lancet; 2016 Jul; 388(10043):505-17. PubMed ID: 26921134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Imaging Insights into Neurodegeneration: Focus on Tau PET Radiotracers.
    Shah M; Catafau AM
    J Nucl Med; 2014 Jun; 55(6):871-4. PubMed ID: 24833492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invited review: Neuropathology of tauopathies: principles and practice.
    Kovacs GG
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):3-23. PubMed ID: 25495175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.